Tag Archives: Justin Keywood

GMP FirstEnergy Believes WELL Health Technologies Corp (TSXV: WELL) Won’t Stop Here

WELL Health Technologies Corp (WELL – Research Report), the Technology company, was revisited by a Wall Street analyst today. The Technology company, WELL Health Technologies Corp (TSXV: WELL) has just received a rating update from a Wall Street analyst. According

GMP FirstEnergy Thinks Canopy Rivers Inc’s Stock is Going to Recover

In a latest note to investors, a research analyst has provided a rating update for the Canopy Rivers Inc (RIV – Research Report). The Financial company, Canopy Rivers Inc (TSXV: RIV) has just received a rating update from a Wall

GMP FirstEnergy Thinks Zenabis Global Inc’s Stock is Going to Recover

Shares of Zenabis Global Inc (ZENA – Research Report) were revisited by a Wall Street analyst yesterday. GMP FirstEnergy’s analyst Justin Keywood reiterates their Buy rating on the shares, with a C$3.25 price target. According to TipRanks.com, Keywood is ranked

GMP FirstEnergy Maintains a Buy Rating on HLS Therapeutics Inc (HLS)

In a new note to investors on August 9, an analyst has provided a rating update for HLS Therapeutics Inc (HLS – Research Report). The Healthcare company, HLS Therapeutics Inc (TSX: HLS) has received a rating update from a Wall

GMP FirstEnergy Remains a Buy on Knight Therapeutics (GUD)

In a new note to investors on August 9, an analyst has provided a rating update for Knight Therapeutics (GUD – Research Report). Analyst Justin Keywood from GMP FirstEnergy rated Knight Therapeutics (GUD – Research Report) a Buy on August

BSM Tech (GPS) Gets a Hold Rating from GMP FirstEnergy

Shares of BSM Tech (GPS – Research Report) were revisited by a Wall Street analyst on February 6. GMP FirstEnergy’s analyst Justin Keywood reiterates their Hold rating on the shares, with a C$0.85 price target. According to TipRanks.com, Keywood is